Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Ordinary Shares, par value $0.000174
Shares outstanding: 55,833,616
Number of holders: 26
Total 13F shares, excl. options: 15,391,128
Shares change: +15,391,128
Total reported value, excl. options: $284,643,000
Value change: +$284,643,000
Number of buys: 26
Price: $18.5

Significant Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB) as of Q1 2021

26 filings reported holding CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 as of Q1 2021.
Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 15,391,128 shares of 55,833,616 outstanding shares and own 27.57% of the company stock.
Largest 10 shareholders include FMR LLC (3,184,989 shares), RA CAPITAL MANAGEMENT, L.P. (2,991,208 shares), BlackRock Inc. (2,450,390 shares), BOXER CAPITAL, LLC (2,081,323 shares), Cormorant Asset Management, LP (1,000,000 shares), WELLINGTON MANAGEMENT GROUP LLP (919,500 shares), JANUS HENDERSON GROUP PLC (475,000 shares), RTW INVESTMENTS, LP (450,000 shares), Farallon Capital Management, L.L.C. (400,000 shares), and Octagon Capital Advisors LP (373,492 shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.